What We're Reading: Page 313
Industry reads hand-picked by our editors
Feb 21, 2017
-
BBC
How drug development is speeding up in the cloud
-
Financial Times
Big pharma bets billions on ‘silent’ liver disease
-
Reuters
Company-funded studies of approved drugs may not catch safety issues
-
Kaiser Health News
Facing pressure, insurance plans loosen rules for covering addiction treatment
-
The Wall Street Journal
Alzheimer’s: pharma’s great white whale is still worth hunting
Feb 17, 2017
-
The Wall Street Journal
FBI searches for possible accomplices in probe of fallen K Street lobbyist
-
Regulatory Focus
House bill seeks to add mandatory drug recall authority to FDA’s arsenal
-
Los Angeles Times
Big pharma really, really doesn't want you to know the true value of its drugs
-
Business Insider
We dug into the drug company Martin Shkreli sold out to the feds, and man is it ugly
-
The Atlantic
The flawed designs of drug trials for autism
Feb 16, 2017
-
Fortune
Why drug companies don’t want President Trump to deregulate the FDA
-
Politico
Humana becomes first major insurer to quit Obamacare exchanges
-
The Baltimore Sun
Health care advocates make pitch for bills to block drug price hikes
-
Bloomberg
Drugmakers boost Indian shares as Sun Pharma snaps losing streak
Feb 15, 2017
-
Reuters
Pharma industry shuns Trump push for radical shift at FDA
-
Healthcare Dive
Aetna, Humana drop merger plans
-
Axios
Uninsured rate is down, but deductibles are up
-
Charleston Gazette-Mail
WV town sues drug firm ‘sharks’ over opioids
-
MIT Technology Review
U.S. panel endorses designer babies to avoid serious disease
Feb 14, 2017
-
The Wall Street Journal
The rise and fall of a K Street renegade
-
Kaiser Health News
Former FDA chief cites 5 things to watch on drug approvals, and keeping drugs safe
-
TheStreet
Stada Arzneimittel shares hit record high after Cinven takeover approach
-
The Tennessean
Tennessee bill would nix drug swaps by insurers, benefit drug industry
Feb 13, 2017
-
Bloomberg
Roche fights Roche for $9 billion drug business
-
Boston Herald
Drug firm payouts under scrutiny
-
The Economist
How to determine a protein’s shape
Feb 10, 2017
-
The Guardian
Cancer drug prices must come down, say leading research institutes
-
Forbes
Mysterious $5 billion biotech Moderna hit with legal setback related to key technology
-
TheStreet
CVS remains unsure about the future of Obamacare, CEO says
-
The New York Times
Doctors see gains against ‘an urgent threat,’ C. diff
Previous
